Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options.

Drugs · 2023 · PMC10581945 · PMID 37737434

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

failed to reach statistical significancep = 0.11not close (p > 0.1)

8.2 months; HR 0.50; p = 0.007) but OS failed to reach statistical significance (44.2 vs. 33.3 months; HR 0.64; p = 0.11) [ 100 ].

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.